CDKN2A and cancer: However, highlighted by the fact that p16INK4a, the critical mediator of this senescence program, is inactivated in approximately one-third of human cancers, the importance of this telomere-independent proliferative arrest in preventing cancer initiation and progression cannot be underestimated (Romagosa et al., 2011).